Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
about
Epidemiology and clinical course of Crohn's disease: results from observational studiesCrohn's disease and growth deficiency in children and adolescentsPatient's perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease.Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's diseaseLong term follow up of through-the-scope balloon dilation as compared to strictureplasty and bowel resection of intestinal strictures in crohn's disease.Current and future role of biomarkers in Crohn's disease risk assessment and treatment.Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in miceA Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel diseaseCrucial steps in the natural history of inflammatory bowel disease.Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)Risk factors for surgical recurrence after ileocolic resection of Crohn's disease.The clinical usefulness of a web-based messaging system between patients with Crohn disease and their physicians.Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approachImmunosuppressive therapies for inflammatory bowel disease.Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesisLooking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease.Postoperative prophylaxis in Crohn's disease after intestinal resection: a retrospective analysis.Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease markerOptimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications.Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota.The optimization of immunosuppressive and biologic cotherapies in inflammatory bowel disease.Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblastsColonic perforation in a child with Crohn's disease: successful medical treatment rescues from colectomyMyeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids.Disparity in Crohn's disease activity between home and clinics is associated with unscheduled hospital visits due to disease flares.Early Intervention with Infliximab Prevents Reoperation in Crohn's Disease: A Single-Center Retrospective Analysis.Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis
P2860
Q22241217-E597078C-3D1E-480C-881C-5F7A7D0F1DB2Q26865160-DD88229D-5242-4488-9C56-B505F1790990Q33756924-404DA789-572F-4A1A-A039-7561B11510CEQ33916303-34C12293-FF2C-43BC-B695-E4C09D470DF2Q33958858-6A352232-0211-4746-8A68-D0D6B7FBA290Q34381832-919B297D-9AB2-460F-BC9B-BFA61F247485Q34540714-F6B2B28B-DC9C-433A-B822-1D4F8EDAE91CQ34733018-2AC919B3-C513-4F56-B391-CEB918102988Q35095265-8E88EE3F-33F2-4052-8EEE-7E8D79E21687Q35510528-3DD49275-E95C-4172-AD4B-5658389D4AA8Q35973766-8C04B9AD-A8FA-4470-A7D8-E7B68BCC635EQ36144457-D94354EE-00D6-47FE-A916-E6F596BD919BQ36848945-E95CB4AD-D547-49F4-A8B2-C41B35311E3EQ36966878-5BA7EAA0-B43C-4933-AA1B-3C007AA11962Q37078010-58FDF832-6A80-4663-8D04-22B785A1A456Q37156633-697DB1F0-827C-40F8-9E3A-5CAFAAFA1C07Q37660661-BA309C4C-9A21-4B3F-99A7-2BBC3F1E7EEBQ37862587-F267C2F0-E63F-47B6-8C4C-DD503571B463Q37892877-98D82D1B-B403-43A3-8DDC-EF7458B8FE54Q38608939-06DC5606-3443-448F-AE5D-981E79750168Q39220077-9F820249-86C7-4E7C-80C6-F4546CE52AC7Q40406061-D9B6F4B7-774B-46EF-8B0E-3E1F75154D7DQ41487887-7DCEBD89-EB03-4C7A-ACBC-971A2707A7D9Q41978311-13E8A54D-B7A6-4AC8-8B59-35AF5E2FAB83Q42044193-5E573940-4449-4825-9876-C6AA6ECC9617Q42471409-50D4F3BE-759E-4F06-9504-6AFCCE17C03FQ47144405-39D9C604-BD4C-4104-81CF-702320415DC5Q47652740-23A7D18C-6DC9-4861-90D9-503F8A346D13Q50044854-2A9FC85A-C6A7-4A20-83AC-6892E9598DCBQ50245126-0E7EB155-1915-46AA-B4F0-8471DEFF09A3Q57472735-44D500D4-2666-4E61-8C38-7F1D0CFF295D
P2860
Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Review article: Altering the n ...... and against current therapies.
@ast
Review article: Altering the n ...... and against current therapies.
@en
type
label
Review article: Altering the n ...... and against current therapies.
@ast
Review article: Altering the n ...... and against current therapies.
@en
prefLabel
Review article: Altering the n ...... and against current therapies.
@ast
Review article: Altering the n ...... and against current therapies.
@en
P2860
P1476
Review article: Altering the n ...... and against current therapies
@en
P2093
Rutgeerts P
van Assche G
P2860
P356
10.1111/J.1365-2036.2006.03134.X
P407
P577
2007-01-01T00:00:00Z